HighTower Advisors »

Cerevel Therapeutics Hldng I shares owned by HighTower Advisors

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.7M 63k 42.17
2023-09-30 $1.6M 74k 21.87
2023-06-30 $2.4M 74k 31.89
2023-03-31 $1.8M 75k 24.26
2022-12-31 $2.4M 75k 31.65
2022-09-30 $2.1M 75k 28.21
2022-06-30 $2.0M 76k 26.39
2022-03-31 $2.7M 76k 35.30
2021-12-31 $2.4M 74k 32.26
2021-09-30 $2.1M 72k 29.70
2021-06-30 $1.8M 72k 25.75
2021-03-31 $914k 67k 13.74
2020-12-31 $752k 45k 16.59